Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents.
Song CaiAubin MoutalJie YuLindsey A ChewJoerg IsenseeReena ChawlaKimberly GomezShizhen LuoYuan ZhouAude ChefdevilleCynthia L MaduraSamantha Perez-MillerShreya Sai BellampalliAngie DorameDavid D ScottLiberty François-MoutalZhiming ShanTaylor WoodwardVijay GokhaleAndrea G HohmannTodd W VanderahMarcel PatekMay KhannaTim HuchoRajesh KhannaPublished in: Science translational medicine (2021)
[Figure: see text].